Terms: = Lung cancer AND PR, PGR, progesterone receptor AND Treatment
1511 results:
1. Phase 1a dose escalation study of ivonescimab (AK112/SMT112), an anti-PD-1/VEGF-A bispecific antibody, in patients with advanced solid tumors.
Frentzas S; Austria Mislang AR; Lemech C; Nagrial A; Underhill C; Wang W; Wang ZM; Li B; Xia Y; Coward JIG
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38642937
[TBL] [Abstract] [Full Text] [Related]
2. The safety and efficacy of Compound Kushen Injection with chemoradiotherapy for the outcomes of lung and gastrointestinal cancers: A PRIMSA-compliant meta-analysis.
Chen Y; Ma M; Xu F
Medicine (Baltimore); 2024 Apr; 103(14):e36758. PubMed ID: 38579051
[TBL] [Abstract] [Full Text] [Related]
3. [A Case of Breast cancer That Developed Pulmonary Tumor Thrombotic Microangiopathy during Adjuvant Chemotherapy].
Okano K; Suzuki T; Abe A; Itaya A; Kameyama Y; Matsumoto S; Hakamada K
Gan To Kagaku Ryoho; 2024 Mar; 51(3):283-285. PubMed ID: 38494809
[TBL] [Abstract] [Full Text] [Related]
4. Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.
Corcoran RB; Do KT; Kim JE; Cleary JM; Parikh AR; Yeku OO; Xiong N; Weekes CD; Veneris J; Ahronian LG; Mauri G; Tian J; Norden BL; Michel AG; Van Seventer EE; Siravegna G; Camphausen K; Chi G; Fetter IJ; Brugge JS; Chen H; Takebe N; Penson RT; Juric D; Flaherty KT; Sullivan RJ; Clark JW; Heist RS; Matulonis UA; Liu JF; Shapiro GI
Clin Cancer Res; 2024 May; 30(9):1739-1749. PubMed ID: 38456660
[TBL] [Abstract] [Full Text] [Related]
5. Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in China.
Yan H; Song L; Li Y; Xu Q; Guo W; Lin S; Jiang W; Wang Z; Deng L; Huang Z; Qin H; Zhang X; Tong F; Zhang R; Liu Z; Zhang L; Yu J; Dong X; Gong Q; Deng J; Chen X; Wang J; Zhang G; Yang N; Zhang Y; Zeng L
Cancer Immunol Immunother; 2024 Mar; 73(4):74. PubMed ID: 38451314
[TBL] [Abstract] [Full Text] [Related]
6. Role of immune checkpoint inhibitors combined with chemotherapy in recurrent drug-resistant gestational trophoblastic neoplasia: Four case reports and literature review.
Liu W; Zhu Y; Wang Y; Li R; Zou D; Chen R; Yang L; Huang Y
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2016. PubMed ID: 38425251
[TBL] [Abstract] [Full Text] [Related]
7. Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective.
Dai F; Chen C; Zhou G; Wang X; Mei L; Luo N; Zhou W; Li T; Deng B; Liu L; Wang Y
Thorac Cancer; 2024 Apr; 15(10):830-846. PubMed ID: 38414317
[TBL] [Abstract] [Full Text] [Related]
8. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report.
Gan J; Liu M; Liu F; Wen J; Fu W; Jia J
BMC Pulm Med; 2024 Feb; 24(1):93. PubMed ID: 38388422
[TBL] [Abstract] [Full Text] [Related]
9. The difference between dacomitinib and afatinib in effectiveness and safety in first-line treatment of patients with advanced EGFR-mutant non-small cell lung cancer: a real-world observational study.
Cheng WC; Lin CC; Liao WC; Lin YC; Chen CH; Chen HJ; Tu CY; Hsia TC
BMC Cancer; 2024 Feb; 24(1):228. PubMed ID: 38373960
[TBL] [Abstract] [Full Text] [Related]
10. Tumor microenvironment(TME) and single-source dual-energy CT(ssDECT) on assessment of inconformity between RECIST1.1 and pathological remission in neoadjuvant immunotherapy of NSCLC.
Sun C; Ma X; Meng F; Chen X; Wang X; Sun W; Xu Y; He H; Zhang H; Ma K
Neoplasia; 2024 Apr; 50():100977. PubMed ID: 38354688
[TBL] [Abstract] [Full Text] [Related]
11. Combination of Polygonatum Rhizoma and Scutellaria baicalensis triggers apoptosis through downregulation of PON
Liu H; Yue L; Li Y; Zheng T; Zhang W; Li C; Zhuang W; Fan L
Environ Toxicol; 2024 May; 39(5):3172-3187. PubMed ID: 38348599
[TBL] [Abstract] [Full Text] [Related]
12. Case report of penile squamous cell carcinoma continuous treatment with BRCA2 mutation.
Zhang Q; Li Y; Zhang Y; Deng Z; Ding Y
World J Surg Oncol; 2024 Feb; 22(1):50. PubMed ID: 38336701
[TBL] [Abstract] [Full Text] [Related]
13. Insensitivity of oncogenic EGFR R776L mutation to EGFR inhibitors in lung cancer.
Wang Y; Hu C; Yu H; Hu J; Zhou Z; Fu N; Huang X; Kong F; Wang W; Liu J
Lung Cancer; 2024 Mar; 189():107495. PubMed ID: 38335691
[TBL] [Abstract] [Full Text] [Related]
14. Radiological complete response with regorafenib for multiple lung metastases of ascending colon cancer: a case report.
Kikuchi K; Ogawa M; Sasaki A
J Med Case Rep; 2024 Feb; 18(1):45. PubMed ID: 38321556
[TBL] [Abstract] [Full Text] [Related]
15. Significant Palliative Benefits Following Therapy With Mifepristone for Advanced treatment Resistant Small Cell lung cancer.
Check JH; Check DL; DO TP; Srivastava M; Check E
Anticancer Res; 2024 Feb; 44(2):659-664. PubMed ID: 38307551
[TBL] [Abstract] [Full Text] [Related]
16. Thoracic SMARCA4-deficient undifferentiated tumor: A clinicopathological and prognostic analysis of 35 cases and immunotherapy efficacy.
Zhou P; Fu Y; Tang Y; Jiang L; Wang W
Lung Cancer; 2024 Mar; 189():107471. PubMed ID: 38306886
[TBL] [Abstract] [Full Text] [Related]
17. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
[TBL] [Abstract] [Full Text] [Related]
18. QL1706 (anti-PD-1 IgG4/CTLA-4 antibody) plus chemotherapy with or without bevacizumab in advanced non-small cell lung cancer: a multi-cohort, phase II study.
Huang Y; Yang Y; Zhao Y; Zhao H; Zhou N; Zhang Y; Chen L; Zhou T; Chen G; Wu T; Lu L; Xue S; Kang X; Zhang L; Fang W
Signal Transduct Target Ther; 2024 Jan; 9(1):23. PubMed ID: 38282003
[TBL] [Abstract] [Full Text] [Related]
19. [A Case of Severe Drug-Induced lung Injury during Preoperative Chemotherapy for Breast cancer in the Early Stages of the COVID-19 Epidemic].
Hirata A; Terasawa R; Takashima Y; Morita S; Kimura K; Iwamoto M; Hayashi M
Gan To Kagaku Ryoho; 2023 Dec; 50(12):1343-1345. PubMed ID: 38247078
[TBL] [Abstract] [Full Text] [Related]
20. Predictive value of peripheral blood biomarkers in patients with non-small-cell lung cancer responding to anti-PD-1-based treatment.
Su S; Chen F; Lv X; Qi L; Ding Z; Ren W; Wei M; Liu Y; Yu L; Liu B; Wang L
Cancer Immunol Immunother; 2024 Jan; 73(1):12. PubMed ID: 38231411
[TBL] [Abstract] [Full Text] [Related]
[Next]
